- Home
- HTBK vs DCTH Comparison
HTBK vs DCTH Comparison
Compare HTBK & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HTBK
- DCTH
- Stock Information
- Founded
- HTBK 1997
- DCTH 1988
- Country
- HTBK United States
- DCTH United States
- Employees
- HTBK N/A
- DCTH N/A
- Industry
- HTBK Major Banks
- DCTH Medical/Dental Instruments
- Sector
- HTBK Finance
- DCTH Health Care
- Exchange
- HTBK Nasdaq
- DCTH Nasdaq
- Market Cap
- HTBK 517.5M
- DCTH 518.0M
- IPO Year
- HTBK 1998
- DCTH N/A
- Fundamental
- Price
- HTBK $8.96
- DCTH $12.11
- Analyst Decision
- HTBK Buy
- DCTH Strong Buy
- Analyst Count
- HTBK 3
- DCTH 4
- Target Price
- HTBK $11.33
- DCTH $22.75
- AVG Volume (30 Days)
- HTBK 338.3K
- DCTH 452.3K
- Earning Date
- HTBK 04-24-2025
- DCTH 05-13-2025
- Dividend Yield
- HTBK 5.83%
- DCTH N/A
- EPS Growth
- HTBK N/A
- DCTH N/A
- EPS
- HTBK 0.68
- DCTH N/A
- Revenue
- HTBK $174,083,000.00
- DCTH $37,205,000.00
- Revenue This Year
- HTBK $9.66
- DCTH $128.78
- Revenue Next Year
- HTBK $4.72
- DCTH $54.07
- P/E Ratio
- HTBK $13.40
- DCTH N/A
- Revenue Growth
- HTBK N/A
- DCTH 1701.69
- 52 Week Low
- HTBK $7.66
- DCTH $5.12
- 52 Week High
- HTBK $11.27
- DCTH $16.97
- Technical
- Relative Strength Index (RSI)
- HTBK 48.24
- DCTH 49.94
- Support Level
- HTBK $8.56
- DCTH $11.74
- Resistance Level
- HTBK $9.27
- DCTH $13.09
- Average True Range (ATR)
- HTBK 0.34
- DCTH 0.83
- MACD
- HTBK 0.10
- DCTH 0.17
- Stochastic Oscillator
- HTBK 73.73
- DCTH 70.39
About HTBK Heritage Commerce Corp
Heritage Commerce Corp operates as a bank holding company. The company, through its subsidiary, offers commercial banking services to small and medium-sized businesses and their owners, managers, and employees. It operates through two reportable segments, namely Banking and Factoring. A majority of its revenue is generated from the Banking segment, which provides various loan products, including commercial and industrial loans, commercial real estate loans, construction loans, etc. This segment also focuses on deposit generation on relationship accounts, encompassing non-interest bearing demand, interest bearing demand, money market accounts, certificates of deposit, and savings accounts.
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.